KR100801435B1 - Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability - Google Patents
Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability Download PDFInfo
- Publication number
- KR100801435B1 KR100801435B1 KR1020050089361A KR20050089361A KR100801435B1 KR 100801435 B1 KR100801435 B1 KR 100801435B1 KR 1020050089361 A KR1020050089361 A KR 1020050089361A KR 20050089361 A KR20050089361 A KR 20050089361A KR 100801435 B1 KR100801435 B1 KR 100801435B1
- Authority
- KR
- South Korea
- Prior art keywords
- chaga
- fermentation
- mushroom
- medium
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229910052760 oxygen Inorganic materials 0.000 title abstract description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title abstract description 8
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 239000001301 oxygen Substances 0.000 title abstract description 8
- 235000019985 fermented beverage Nutrition 0.000 title description 4
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- 235000000346 sugar Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000001954 sterilising effect Effects 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 6
- 239000011707 mineral Substances 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 6
- 241001148470 aerobic bacillus Species 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 41
- 238000000034 method Methods 0.000 abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 9
- 235000013824 polyphenols Nutrition 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001473 noxious effect Effects 0.000 abstract 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 10
- 235000018212 Betula X uliginosa Nutrition 0.000 description 10
- 239000000203 mixture Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000005996 Blood meal Substances 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- KKWJCGCIAHLFNE-UHFFFAOYSA-N 22R-hydroxylanosterol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(C(O)CC=C(C)C)C)CCC21C KKWJCGCIAHLFNE-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000414067 Inonotus obliquus Species 0.000 description 1
- CSYGXJQNODZRQO-UHFFFAOYSA-N Inotodiol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CC(O)C12C)C4(C)CCC(O)C(C)(C)C4CC3 CSYGXJQNODZRQO-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010565 inoculated fermentation Methods 0.000 description 1
- KKWJCGCIAHLFNE-KFPHZHIMSA-N inotodiol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H]([C@H](O)CC=C(C)C)C)CC[C@]21C KKWJCGCIAHLFNE-KFPHZHIMSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- -1 phenol aldehydes Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 시베리아 지역에서 16세기를 전후한 시기부터 불치병을 치료하는 민간 비약(秘藥)으로 전해져 내려왔으며, 과학적인 연구가 뒷받침된 현대에 이르러서 러시아 병원에서 암치료를 위해 공식적으로 처방되는 약초(Herb)로 인정받고 있으며, 항종양 활성, 항노화 작용이 뛰어난 차가 버섯을 이용하여 건강 음료를 제조하는 방법에 관한 것으로, 대부분이 버섯 자체를 농산물의 형태로 유통하고 있고, 일부 제품의 경우 단순히 추출 후 포장한 제품을 판매하고 있으나 본 발명에서는 차가버섯 유효성분을 극대화 할 수 있는 과학적인 방법 특히 유해 산소 제거 능력이 뛰어나게 만드는 발효법에 의한 음료 제조법을 개발하고자 하였다. 이를 위하여 본 발명은, 차가버섯을 세척하는 단계, 차가버섯, 흑설탕, 광천수를 주성분으로 하여 발효를 위한 배지를 조성하는 단계, 121℃로 15분간 살균하는 단계, 상온까지 냉각한 배지에 발효미생물을 접종하는 단계, 20~30℃의 온도에서 발효하는 단계, 여과 후 병입하여 살균하는 단계로 이루어진 것에 특징이 있다.The present invention has been handed down as a private elixir for treating incurable diseases since around the 16th century in Siberia, and in the modern era supported by scientific research, the herb is officially prescribed for cancer treatment in Russian hospitals. Herb), which is a method of manufacturing healthy drinks using chaga mushroom with excellent anti-tumor activity and anti-aging effect, most of which distribute mushroom itself in the form of agricultural products, and some products are simply extracted. After selling the packaged product, in the present invention, a scientific method for maximizing chaga effective ingredients, in particular, to develop a beverage production method by the fermentation method that makes excellent the ability to remove harmful oxygen. To this end, the present invention, the step of washing chaga mushroom, chaga mushroom, brown sugar, mineral water as a main component to form a medium for fermentation, sterilizing for 15 minutes at 121 ℃, the fermentation microorganisms in the medium cooled to room temperature Inoculating, fermentation at a temperature of 20 ~ 30 ℃, characterized in that consisting of sterilization by bottling after filtration.
차가버섯, 발효, 유해산소제거, EDA, 총폴리페놀 Chaga, Fermented, Noxious Oxygen, EDA, Total Polyphenols
Description
도 1은 차가버섯을 열탕 추출한 것의 EDA 변화1 is a change of EDA of boiling water chaga
도 2는 차가버섯을 열탕 추출한 것의 총폴리페놀함량 변화2 is a change in total polyphenol content of hot water extracted chaga mushroom
도 3은 발효 온도에 따른 EDA 변화3 is the change in EDA according to the fermentation temperature
도 4는 발효 온도에 따른 총폴리페놀 함량의 변화4 is a change of the total polyphenol content with the fermentation temperature
본 발명은 높은 유해 산소 제거 능력을 갖는 차가버섯 발효 음료의 제조에 관한 것으로, 보다 상세하게는 차가버섯, 흑설탕, 광천수를 주성분으로 하는 배지에 발효미생물을 접종하여 발효 후 여과 병입하는 차가버섯 발효 음료 제조 방법에 관한 것이다. The present invention relates to the production of chaga mushroom fermented beverage having a high harmful oxygen removal ability, more specifically chaga mushroom fermented beverage inoculated with the fermentation microorganisms inoculated fermentation microorganisms in a medium containing chaga, brown sugar, mineral water as a main component It relates to a manufacturing method.
차가버섯은 북위 45℃ 이상 되는 러시아 시베리아를 중심으로 캐나다, 미국 등의 북아메리카에서 유럽의 스칸디나비아 반도에 이르기까지 광대하게 펼쳐져 있는 타이가 기후대의 자작나무 삼림지대에서 자생한다. 또한 강원도 일부, 일본 홋카이도에서도 간혹 소량으로 발견되기도 한다. 차가버섯은 버섯의 특징을 지니고 있으면서 동시에 일반 버섯과는 확연히 차별되는 특징도 가지고 있다. 차가버섯은 포자로 번식되지 않고 자작나무에 침투한 바이러스가 자작나무와 싸우면서 생겨나는 특이한 생명체이며 시베리아 등 혹한 지역의 살아있는 자작나무에서 자생하는 매우 독특한 버섯이다. 차가버섯의 성장과정은 자작나무의 상처를 통해 침투한 바이러스가 자작나무와 싸우는 과정을 통해 암과 같은 변종의 생명체가 생겨나고, 이것이 자작나무 내부에서 목질 부분을 제거하며 자리 잡고, 자작나무의 몸속에 2m에 이르는 긴 뿌리를 내려 수액과 목질은 물론, 자작나무가 생존을 위해서 만들어 내는 플라보노이드까지 섭취하면서 7년 이상 성장한다. 그 후 껍질을 깨고 표면으로 나와 외부에서 2차로 성장을 하면서 비로소 차가 버섯의 형태를 갖추게 된다. 처음 껍질을 깨고 나온 어린 차가버섯은 전체 두께가 얇고 까만 겉껍질과 고동색 살 부분으로 되어 있다. 차가버섯이 밖으로 나온 다음 나무속에서 느끼지 못했던, 혹한(-50°C 이하)의 시베리아 강추위에서 살아남기 위해 껍질의 두께를 급속히 늘려 가는데, 까만 겉껍질은 자라는 속도가 느려서 겉껍질 밑에 속껍질을 만들면서 두께를 늘려 간다. 15년 이상 혹한에서 나이를 먹고 천천히 성장한 차가버섯의 겉껍질(표면)은 균열도 깊고 단단하며 속 부분의 살도 돌처럼 단단해 지면서 밝은 색을 띠는 엽맥이 발견된다. 1520년 (간혹 드물게 그 이상) 정도 지나면 자작나무는 차가버섯 때문에 죽어가며 차가버섯도 자작나무와 함께 그 생을 마감하게 된다. Chaga mushrooms grow in birch woodland in the taiga climatic region, which extends from North America, Canada and the United States, to Scandinavian Peninsula in Europe, mainly in Siberia, Russia, which is over 45 ° C. It is also sometimes found in small quantities in parts of Gangwon-do and Hokkaido, Japan. Chaga has the characteristics of mushrooms, and at the same time, it is distinct from ordinary mushrooms. Chaga is a unique creature that is not produced by spores, but a virus that infiltrates the birch and fights the birch. It is a very unique mushroom that grows in living birch in harsh regions such as Siberia. The growth process of chaga is caused by a virus that penetrates through the wounds of the birch and fights the birch, forming a life-like variety of cancer, which is settled by removing wood parts from the inside of the birch. It grows for more than seven years by taking long roots up to 2 meters long and taking in sap and wood, as well as the flavonoids that birch makes for survival. After that, the shell breaks out of the surface and grows secondarily from the outside until the tea becomes a mushroom. The young chaga mushroom that first broke its shell is thin, with black outer skin and maroon flesh. After the chaga came out, it quickly increased in thickness to survive in the cold (<-50 ° C) Siberian cold, which was not felt in the trees. To increase. Chaga mushroom's outer skin (surface) grows deeper and harder in cold weather for more than 15 years, and the inner part of the flesh becomes hard as stone, and brightly colored leaf veins are found. After 1520 (sometimes rarely), birch trees die from chaga, and chaga end up with birch.
순수과학잡지 러시아판(2003년 8호)의 미이라와 차가버섯에 의하면 1991년 알프스산맥에서 발견된 5,300년 된 미이라의 가방에 2개의 차가버섯 조각이 들어 있었다. 오스트리아 인스부르그 대학의 Jim Dickson, Klaus Oeggl 교수와 세계적인 고고 환경생리학자 Linda Handley 박사가 참여한 연구팀에서 이 미이라의 직업, 나이 그때의 의료 환경, 기후 등과 함께 이 미이라가 가지고 있던 차가버섯은 사람에게 사용할 목적으로 소지하고 있었다는 사실을 밝혀냈다. 시베리아 지역에서는 대략 16세기 이전부터 민가에서 사용되어 왔으며, 과학적인 연구가 이루어지기 시작한 것은 19세기 후반이었다. 1951년 소련 과학아카데미 산하 V. L. 코마로프 식물학연구소와 모스크바 의학아카데미에서 지원받은 N. K. 불라토바 교수, M. P. 베레지노이 교수, P. A. 야키모바 교수로 구성된 러시아 약제 연구소에서부터 차가버섯에 대한 연구가 본격적으로 이루어지기 시작했다. 현재 러시아에서는 차가버섯에 대해, 자연물인 덩어리는 농산물로 분류되어 약국에서는 취급을 할 수가 없으나 분쇄 이상의 가공을 한 제품은 약품으로 인정하여, 약국에서 공식적으로 판매를 하고 있다. According to the mummy and chaga mushroom in the Russian edition of the Pure Sciences magazine (8th issue of 2003), two chaga pieces were contained in a 5,300-year-old mummy bag found in the 1991 Alps. In a research team involving Jim Dickson, professor Klaus Oeggl and Dr. Linda Handley, an international archaeological physiologist at the University of Innsbruck, Austria, the muga's chaga, together with the mummy's occupation, the medical environment at that time, and the climate, was intended for human use. Revealed that he was possessing. In Siberia, it has been used in private houses since the early 16th century, and scientific research began in the late 19th century. In 1951, research on chaga began in earnest from the Russian Institute of Pharmaceutical Sciences, which consisted of the VL Komarov Botanic Research Institute under the Soviet Academy of Science and the NK Bulatova, MP Beresinoi, and PA Yakimova, supported by the Moscow Academy of Medicine. . In Russia, chaga is a natural product, but agglomerates are classified as agricultural products and cannot be handled at pharmacies. Products processed more than ground are recognized as drugs and are officially sold at pharmacies.
차가버섯의 화학적 성분은 다음과 같다. 차가버섯에는 12.3%미만의 재가 함유되어 있는데, 이 재 속에는 SiO2, Fe2O3, Al2O3, CaO, MgO, Na2O, K2O, ZnO, CuO, Mn2O3 등의 산화물들이 포함되어 있으며 다량의 칼륨이 함유되어 있다. 차가버섯에서는 수산(oxalic acid), 의산(개미산), 초산, 낙산, 바닐린산, 파라옥시벤조, 테트라사이클린 트리테르펜 그룹의 두 개의 트리테르펜산(triterpene acid), 오블리크비노산, 이노노토산 등의 산들이 검출되었다. 또한 프리페놀, 다당류(이것의 가수분해의 결과로 환원당이 만들어진다), 프테린, 리그닌, 세포막질, 스테린-에르고스테롤, 라노스테롤, 이노토디올 등이 함유되어 있다. 차가의 주요 생물학적 활성 물질로 간주되는 것은 수용성 크로모겐(chromogen)인데, 이것은 화학적 활성을 지닌 페놀 알데이드, 폴리페놀, 옥시페놀카본산 및 그것들의 퀴논(quinone) 복합체로 형성된 것이다. 크로모겐 복합체에서는 휴민(humin) 유사물질들이 추출되는데, 이 물질들의 분해물이 포도당, 갈락토스, 자일로스 등이다.The chemical composition of chaga is as follows. Chaga contains less than 12.3% ash, which contains SiO 2 , Fe 2 O 3 , Al 2 O 3 , CaO, MgO, Na 2 O, K 2 O, ZnO, CuO, Mn 2 O 3, etc. It contains oxides and contains large amounts of potassium. In chaga, oxalic acid, medicinal acid (formic acid), acetic acid, butyric acid, vanillic acid, paraoxybenzo, tetraterpene acid of tetracycline triterpene group, obliquebinoic acid, inonotosan, etc. Acids were detected. It also contains prephenols, polysaccharides (reducing sugars as a result of its hydrolysis), pterins, lignin, cell membranes, steriner-ergosterol, lanosterol, inotodiol and the like. Considered as the primary biologically active substance of Chaga is water soluble chromogen, which is formed from phenol aldehydes, polyphenols, oxyphenolcarboxylic acids and their quinone complexes with chemical activity. Humin-like substances are extracted from the chromogen complex, the breakdown of which is glucose, galactose and xylose.
최근 일본에서 연구된 내용에 의하면 다른 버섯들과 비교하여 유효성분들이 매우 높음이 밝혀졌다. 차가버섯의 영양학적 성분은 표1에, 다른 버섯과의 성분 비교는 표2에 나타내었다. Recent studies in Japan have shown that the active ingredients are very high compared to other mushrooms. The nutritional components of chaga are shown in Table 1, and the comparison with other mushrooms is shown in Table 2.
※분석기관: 일본 식품 분석센터 ※ Institution: Japan Food Analysis Center
※분석기관: 일본 북해도립 식품가공센터 ※ Institution: Japan Hokkaido Food Processing Center
이 분야와 관련된 종래 특허 기술을 살펴보면 대부분 열탕 추출에 의해 유효 성분을 얻는 것이고, 직접적으로 관련 있는 특허 출원은 차가버섯 발효 조성물의 제조방법 및 그 용도(A method for preparation of fermented Inonotus Obliquus and the use thereof)에 관한 것으로 차가버섯의 기능성을 증대시키기 위하여 차가버섯 분말 단독을 원료로 하거나 차가버섯 분말에 설록차 또는 어성초를 혼합한 것을 원료로 하여 콩, 혈분 및 설탕의 혼합물을 발효시켜 얻어진 발효 미생물원을 상기 원료에 첨가하고 이들을 발효시킴으로써 차가버섯 발효 조성물을 제조하는 방법에 관한 것으로, 청구항은 콩, 혈분, 설탕을 혼합하고 이들 혼합물을 자연 발효시킴으로써 차가버섯 발효를 위한 발효 미생물원을 얻는 단계; 및 상기 단계에서 얻어진 발효 미생물원을 차가버섯 분말에 첨가하여 발효시키는 것을 특징으로 하는 차가버섯 발효물의 제조방법에 관한 것이다. 그러나, 본 발명에서는 차가버섯분말을 사용하지 않고 차가버섯덩어리 통째로를 사용하고, 설록차 또는 어성초를 혼합하지 않고 차가버섯 자체만을 사용한다. 미생물 접종원의 경우도 콩, 혈분 및 설탕의 혼합물을 발효시켜 사용하지 않고, 실험실에서 일반적으로 사용하는 Nutrient Broth를 배지로 사용하였다. 그리고, 본 발명은 차가버섯을 세척하는 단계, 차가버섯, 흑설탕, 광천수를 주성분으로 하여 발효를 위한 배지를 조성하는 단계, 121℃로 15분간 살균하는 단계, 상온까지 냉각한 배지에 유산균과 호기성 세균이 혼합되어 있는 것을 접종하는 단계, 20~30℃의 온도에서 발효하는 단계, 여과 후 병입하여 살균하는 단계로 이루어져서 상기의 출원과는 재료 및 방법이 근본적으로 다르다고 할 수 있다.Looking at the conventional patent technology related to this field is to obtain the active ingredient mostly by boiling water extraction, the directly related patent application is a method for preparation of fermented Inonotus Obliquus and the use ) Is a fermentation microorganism obtained by fermenting a mixture of soybeans, blood meal and sugar using chaga mushroom powder alone or chaga mushroom powder as a raw material in order to increase the functionality of chaga mushroom. The present invention relates to a method for preparing a chaga mushroom fermentation composition by adding to a raw material and fermenting the same, wherein the claim comprises: obtaining a fermentation microorganism source for chaga mushroom fermentation by mixing soybean, blood meal and sugar and naturally fermenting the mixture; And it relates to a method for producing chaga mushroom fermentation, characterized in that the fermentation microbial source obtained in the step is added to the chaga mushroom powder and fermented. However, in the present invention, without using chaga mushroom powder, the whole chaga mushroom mass is used, and only chaga mushroom itself is used without mixing sulloc tea or eoseongcho. In the case of microbial inoculum, a mixture of soybean, blood meal and sugar was not used to ferment, but Nutrient Broth, which is generally used in a laboratory, was used as a medium. In addition, the present invention comprises the steps of washing chaga mushroom, chaga mushroom, brown sugar, mineral water as a main component to form a medium for fermentation, sterilizing for 15 minutes at 121 ℃, the medium cooled to room temperature and lactic acid bacteria Inoculating a mixture of aerobic bacteria, the step of fermentation at a temperature of 20 ~ 30 ℃, filtration and bottling step of sterilization, it can be said that the material and method is fundamentally different from the above application.
본 발명을 통해 최근 민간요법에서 항암, 항당뇨 효과로 큰 관심을 끌고 있으며, 항종양 활성, 항노화 작용이 뛰어난 차가 버섯을 이용하여 건강 음료를 제조하는 기술을 개발하고자 한다. 일반적으로 사용되는 단순 열탕 추출이 아닌 차가버섯 유효성분을 극대화 할 수 있는 과학적인 방법, 특히 유해산소 제거능력이 뛰어나게 만드는 발효법에 의해 음료를 제조하는 기술의 확립이 본 발명을 통해 이루고자 하는 기술적 과제이다. Through the present invention has recently attracted great attention as anti-cancer, anti-diabetic effect in folk medicine, and to develop a technology for producing a healthy drink using chaga mushroom excellent anti-tumor activity, anti-aging action. The technical problem to be achieved through the present invention is to establish a technology for producing beverages by a fermentation method that makes it possible to maximize the effective chaga removal ability, not the simple boiling water extraction commonly used chaga extract. .
상기의 목적을 달성하기 위하여, 본 발명은 차가버섯을 세척하는 단계; 세척된 미분말상 차가버섯, 흑설탕, 광천수를 주성분으로 하여 발효를 위한 배지를 조성하는 단계; 상기 배지를 121℃로 15분간 살균하는 단계; 상온까지 냉각한 배지에 유산균과 호기성 세균이 혼합된 발효미생물을 접종하는 단계; 20~30℃의 온도에서 발효하는 단계; 여과 후 병입하여 살균하는 단계로 이루어진다.In order to achieve the above object, the present invention comprises the steps of washing chaga; Preparing a medium for fermentation based on washed fine powder chaga, brown sugar, and mineral water; Sterilizing the medium at 121 ° C. for 15 minutes; Lactobacillus and medium in a medium cooled to room temperature Inoculating fermented microorganisms mixed with aerobic bacteria; Fermentation at a temperature of 20 ~ 30 ℃; It consists of sterilization by bottling after filtration.
< 시험예 1 > <Test Example 1>
본 시험예는 2002년에 발행된 한국식품과학회지 34권 3호 498페이지부터 504페이지에 나와 있는 EDA 측정법을 활용하여 다음과 같이 분석하였다. 차가버섯의 단순 열탕 추출액 100μL 또는 차가버섯의 발효액 100μL에 1X10-4M DPPH(α,α-diphenyl-β-picrylhydrazyl) 1,400μL를 합하여 4분간 반응시키고 12,000rpm에서 3분간 원심분리한 후 상등액만 취한다. 상등액을 10분간 반응시키고 분광광도계를 사용하여 525nm에서 흡광도를 측정한다. 측정된 흡광도는 아래식에 넣어 EDA 값을 구한다. This test example was analyzed using the EDA measurement method described in the Korean Food Science Society, 34, No. 3, page 498-4504 published in 2002 as follows. 100 μL of chaga mushroom extract or 1,400 μL of 1X10-4M DPPH (α, α-diphenyl-β-picrylhydrazyl) is added to 100 μL of Chaga mushroom fermentation broth for 4 minutes, centrifuged at 12,000 rpm for 3 minutes, and then the supernatant is taken. . The supernatant is reacted for 10 minutes and the absorbance is measured at 525 nm using a spectrophotometer. The measured absorbance is calculated by the following equation to obtain the EDA value.
EDA(%) = 1 - ( 샘플의 흡광도 / 증류수의 흡광도) X 100EDA (%) = 1-(absorbance of sample / absorbance of distilled water)
< 시험예 2 ><Test Example 2>
총 폴리페놀화합물은 Folin-Ciocalteu reagent가 추출물의 폴리페놀성 화합물에 의해 환원된 결과 몰리브덴 청색으로 발색하는 것을 원리로 분석하였다. 시료 10 mℓ와 50% Folin-Ciocalteu's resent solution 0.1mℓ를 혼합하여 실온에서 3분간 방치한 후 분광 광도계(BECKMAN. DU-650. USA)를 사용하여 760nm에서 흡광도를 측정하였다. 표준물질로 gallic acid를 사용하였으며. 검량선을 작성 후 추출물의 총 폴리페놀 함량을 건조된 차가버섯 100g중의 mg gallic acid로 나타내었다. The total polyphenolic compound was analyzed on the basis that the Folin-Ciocalteu reagent was developed by molybdenum blue as a result of reduction by the polyphenolic compound of the extract. 10 ml of the sample and 0.1 ml of the 50% Folin-Ciocalteu's resent solution were mixed and left at room temperature for 3 minutes, and then absorbance was measured at 760 nm using a spectrophotometer (BECKMAN. DU-650. USA). Gallic acid was used as a standard. After preparing the calibration curve, the total polyphenol content of the extract was expressed as mg gallic acid in 100 g of dried Chaga.
< 시험예 3 > <Test Example 3>
일반적으로 사용되는 차가버섯의 단순 열탕 추출과 차가버섯의 발효액을 비교하기 위하여, 반응 온도와 반응 시간을 여러 가지로 달리하여 추출하였다. 차가버섯의 단순 열탕추출의 경우는 반응후 여과하여 준비하였고, 차가버섯 발효액의 경우는 발효 진행 도중 일정 시간에 꺼내어 여과하여 준비하였다. 이때 각 반응 온도 및 반응 시간에서 실험한 샘플들에 대해 유해 산소 제거 능력의 지표로 EDA와 총 폴리페놀함량의 변화를 측정하였고, 그 결과는 도1과 도2에 나타내었다. In order to compare the simple boiling water extraction of chaga mushroom and the fermentation broth of chaga which are commonly used, the reaction temperature and the reaction time were extracted in various ways. Simple boiling water extraction of chaga mushroom was prepared after the reaction by filtration, chaga mushroom fermentation broth was taken out at a certain time during the fermentation process and prepared by filtration. At this time, the change of EDA and total polyphenol content was measured as an indicator of the toxic oxygen removal capacity for the samples tested at each reaction temperature and reaction time, the results are shown in Figures 1 and 2.
< 시험예 4 > <Test Example 4>
차가버섯 유효성분을 극대화 할 수 있는 방법 특히 유해 산소 제거 능력이 뛰어나게 만드는 발효법에 의한 음료 제조법을 개발하고자 하여 다음과 같이 실험하였다. 차가버섯을 세척하는 단계, 차가버섯, 흑설탕, 광천수를 주성분으로 하여 발효를 위한 배지를 조성하는 단계, 121℃로 15분간 살균하는 단계, 상온까지 냉각한 배지에 유산균과 호기성 세균이 혼합되어 있는 것을 접종하는 단계, 20~30℃의 온도에서 발효하는 단계, 여과 후 병입하여 살균하는 단계로 실험을 진행하였고, 각각의 실험 조건에서 취한 샘플들에 대해 유해 산소 제거 능력의 지표로 EDA와 총 폴리페놀함량의 변화를 측정하였다. 그 결과는 도3과 도4에 나타내었다.In order to develop a method of maximizing the active ingredient of chaga mushroom, in particular, to develop a beverage production method by fermentation method that makes it excellent in removing harmful oxygen, the following experiment was conducted. Washing chaga, chaga, brown sugar, mineral water as a main ingredient to form a medium for fermentation, sterilizing for 15 minutes at 121 ℃, the medium cooled to room temperature and lactic acid bacteria and The experiment was carried out by inoculating a mixture of aerobic bacteria, fermentation at a temperature of 20 ~ 30 ℃, sterilization by bottling after filtration, and the ability to remove harmful oxygen for the samples taken under each experimental condition. Changes in EDA and total polyphenol content were measured as indicators. The results are shown in FIGS. 3 and 4.
현재 대부분의 차가버섯이 버섯 자체를 농산물의 형태로 유통하고 있고, 일부 제품의 경우 단순히 열탕 추출 후 포장한 제품을 판매하고 있으나, 본 발명에 의한 제품 생산이 이루어질 경우 차가버섯 유효성분을 극대화 할 수 있고 특히 유해 산소 제거 능력이 뛰어난 차가버섯 발효음료를 만들 수 있다. 항종양 활성, 항노화 작용이 뛰어난 차가 버섯의 유효 성분 이용성을 증진할 수 있고, 건강식품으로의 상품화를 통해 수요 창출과 고부가가치의 창출이 가능하며, 국민 보건 향상에 이바지할 수 있다. Currently, most chaga mushrooms are distributed in the form of agricultural products, and some products are simply sold after extraction of hot water packaged products, but if the production of the product according to the present invention can maximize the active ingredient of chaga In particular, it is possible to make chaga fermented beverages with excellent removal of harmful oxygen. Chaga mushroom, which has excellent antitumor activity and anti-aging effect, can improve the usability of active ingredients, and it can create demand and create high value through the commercialization of health food, and contribute to the improvement of public health.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050089361A KR100801435B1 (en) | 2005-09-26 | 2005-09-26 | Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050089361A KR100801435B1 (en) | 2005-09-26 | 2005-09-26 | Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070034801A KR20070034801A (en) | 2007-03-29 |
KR100801435B1 true KR100801435B1 (en) | 2008-02-11 |
Family
ID=41339355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050089361A Expired - Fee Related KR100801435B1 (en) | 2005-09-26 | 2005-09-26 | Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100801435B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101377586B1 (en) | 2013-01-29 | 2014-03-25 | 김동명 | Method for producing fermented inonotus obliquus with increased antioxidant activity and total phenolic compounds by the solid-state fermentation |
CN105495551A (en) * | 2015-12-10 | 2016-04-20 | 于蜀豪 | Inonotus obliquus probiotic enzyme and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102105316B1 (en) * | 2018-11-16 | 2020-05-29 | 농업회사법인(주)백세 | Process for producing functional beverage using mixed fermented extract of Inonotus Obliquus, Phellinus linteus and Ganoderma lucidum fermented with probiotic Lactobacillus and functional drinks thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030042307A (en) * | 2001-11-22 | 2003-05-28 | 주식회사 바이오허브 | The method of manufacturing a mushroom lactic acid fermented solution and the s0lution manufactured thereby |
-
2005
- 2005-09-26 KR KR1020050089361A patent/KR100801435B1/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030042307A (en) * | 2001-11-22 | 2003-05-28 | 주식회사 바이오허브 | The method of manufacturing a mushroom lactic acid fermented solution and the s0lution manufactured thereby |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101377586B1 (en) | 2013-01-29 | 2014-03-25 | 김동명 | Method for producing fermented inonotus obliquus with increased antioxidant activity and total phenolic compounds by the solid-state fermentation |
CN105495551A (en) * | 2015-12-10 | 2016-04-20 | 于蜀豪 | Inonotus obliquus probiotic enzyme and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20070034801A (en) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2689951C1 (en) | Mushrooms production method | |
KR101279959B1 (en) | Manufacturing Method of Fermented Materials using Wax Gourd and Functional food of Thereof Manufacturing | |
KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
KR102298700B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg | |
CN114304618B (en) | Method for enriching dandelion root active ingredients through fermentation and application of method | |
CN103263448A (en) | Fermentation bacteria used for fermentation pretreatment to improve extraction of Ginkgo biloba L. leaf flavone and application | |
KR102648639B1 (en) | Rice cake composition with anti-oxidation effect and rice cake manufactured from the same composition | |
KR101663379B1 (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
WA et al. | Bioactive potential of some fascinating edible mushrooms Macrolepiota, Russula, Amanita, Vovariella and Grifola as a treasure of multipurpose therapeutic natural product | |
CN103431292A (en) | Health care noodle containing bullacta exarata polypeptides and plant extract powder | |
KR20120071932A (en) | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity | |
KR100801435B1 (en) | Manufacturing method of chaga fermented beverage having high harmful oxygen removal ability | |
KR20220054023A (en) | A composition for immune enhancement comprising benicasa hispida extract | |
KR102563199B1 (en) | Mushroom scorched rice manufacturing method using cordyceps sinensis and mushroom scorched rice prepared thereby | |
KR102507651B1 (en) | Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method | |
KR101276157B1 (en) | Cheonggukjang's manufacturing method and medium for improving the color and flavor and maintaining functionality | |
KR102151573B1 (en) | Herb vinegar and manufacturing method thereof | |
KR101918890B1 (en) | Pollen Fermented liquid composition using glacial water and method of producing the same | |
KR20230150912A (en) | A feed additive comprising benicasa hispida fermented-extract or benicasa hispida fermented-material | |
KR100824035B1 (en) | Method to Control Kimchi Fermented Strains Using Mixture of Green Tea, Dandelion and Cordyceps Sinensis | |
KR101611881B1 (en) | Method for producing Phellinus linteus mycelium pressurized extract with increased antioxidant and whitening activity cultured in Mori ramulus medium | |
KR20040062000A (en) | Utilization and processing of mushroom products fermented by lactic acid bacteria inhibiting helicobactor pylori and harmful enzymes in colon | |
KR102070613B1 (en) | Fermented products using dendropanax morbifera and sweet potatoes, their preparation method, and functional products using the same | |
KR102089045B1 (en) | A fermented grain and method fot preparing thereof | |
KR101915180B1 (en) | Lotus Leached Tea and Manufacturing Method Thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20050926 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061031 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070725 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080128 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080129 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20080129 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
PG1701 | Publication of correction | ||
PR1001 | Payment of annual fee |
Payment date: 20110127 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20120117 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130115 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20130115 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140114 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20140114 Start annual number: 7 End annual number: 7 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20151209 |